None
Quote | Knight Therapeutics Inc (OTCMKTS:KHTRF)
Last: | $3.92 |
---|---|
Change Percent: | -0.56% |
Open: | $4.041 |
Close: | $3.92 |
High: | $4.041 |
Low: | $3.92 |
Volume: | 6,211 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Knight Therapeutics Inc (OTCMKTS:KHTRF)
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list. This an...
2024-03-21 12:15:22 ET Knight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Conference Call March 21, 2024 8:30 AM ET Company Participants Samira Sakhia - President and Chief Executive Officer and Director Arvind Utchanah - Chief Financial Officer Amal Khouri - Chie...
Message Board Posts | Knight Therapeutics Inc (OTCMKTS:KHTRF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Knight Therapeutics Inc Company Name:
KHTRF Stock Symbol:
OTCMKTS Market:
MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list. This an...
MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2023. All currency ...
MONTREAL, March 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2023 financial results on Thursday, March 21, 2024 prior to market opening. Fol...